Clinical outcomes of subtalar arthroereisis for the treatment of stage 1 flexible progressive collapsing foot deformity
European Journal of Orthopaedic Surgery & Traumatology · 30.05.2024 · 34 (6) · 2933-2940
DOI: 10.1007/s00590-024-04007-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, online erschienen am 30.05.2024. Verfasst von Thomas L Lewis und 5 weiteren Autor:innen. Beteiligte Einrichtung: King's Foot and Ankle Unit, King's College Hospital NHS Foundation Trust, London, UK. t.lewis2@nhs.net. Hauptthemen laut MEDLINE: Subtalar Joint, Quality of Life. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The use of subtalar arthroereisis as an adjunct to the surgical treatment of stage 1 flexible progressive collapsing foot deformity (PCFD) is controversial. The aim was to investigate the clinical outcomes and report the implant removal rate of subtalar arthroereisis as an adjunct for stage 1 PCFD.
Methods
A retrospective study of 212 consecutive feet undergoing operative management of stage 1 PCFD with adjunctive subtalar arthroereisis between October 2010 and April 2018. The primary outcome was the Foot and Ankle Outcome Score (FAOS). Secondary outcomes included Foot and Ankle Disability Index (FADI), Euroqol-5D-5L Index and implant removal rate.
Results
Post-operative clinical FAOS outcomes were collected for 153 feet (72.2%). At mean 2.5-year follow-up, the mean ± standard deviation FAOS for each domain was as follows; Pain: 81.5 ± 18.5, Symptoms: 79.5 ± 12.9, Activities of Daily Living: 82.5 ± 15.4 and Quality of Life: 64.2 ± 23.7. EQ-5D-5L Index was 0.884 ± 0.152. Pre-operative scores were available for 20 of these feet demonstrating a statistically significant improvement in all FAOS, FADI and EQ-5D-5L domains ( p < 0.05). The implant removal rate for persistent sinus tarsi pain was 48.1% ( n = 102).
Conclusion
Use of a subtalar arthroereisis implant as an adjunct to conventional procedures in stage 1 flexible PCFD can result in significant improvement in pain and function. Patients should be counselled as to the relatively frequent rate of subsequent implant removal. Level of evidence IV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King's Foot and Ankle Unit, King's College Hospital NHS Foundation Trust, London, UK. t.lewis2@nhs.net.
- Mid Yorkshire Hospitals NHS Trust, Wakefield, UK.
- King's Foot and Ankle Unit, King's College Hospital NHS Foundation Trust, London, UK.
- Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
- North Sydney Orthopaedic and Sports Medicine Centre, Wollstonecraft, Australia.
Zitieren
APA
Lewis, T. L., Goff, T. A. J., Ray, R., Dhaliwal, J., Carmody, D., & Wines, A. P. (2024). Clinical outcomes of subtalar arthroereisis for the treatment of stage 1 flexible progressive collapsing foot deformity. European Journal of Orthopaedic Surgery & Traumatology, 34(6), 2933-2940. https://doi.org/10.1007/s00590-024-04007-4
Vancouver
Lewis TL, Goff TAJ, Ray R, Dhaliwal J, Carmody D, Wines AP. Clinical outcomes of subtalar arthroereisis for the treatment of stage 1 flexible progressive collapsing foot deformity. European Journal of Orthopaedic Surgery & Traumatology. 2024;34(6):2933-2940. doi:10.1007/s00590-024-04007-4
BibTeX
@article{Lewis2024,
author = {Lewis, Thomas L and Goff, Thomas A J and Ray, Robbie and Dhaliwal, Jagwinder and Carmody, David and Wines, Andrew P},
title = {Clinical outcomes of subtalar arthroereisis for the treatment of stage 1 flexible progressive collapsing foot deformity},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2024},
volume = {34},
number = {6},
pages = {2933--2940},
doi = {10.1007/s00590-024-04007-4}
}
EUVIMED